Enlivex (ENLV) Preferred Shares (2017 - 2018)
Enlivex (ENLV) posted quarterly Preferred Shares of $309000.0 for Q4 2018, little changed year-over-year from $309000.0 in Q4 2017, and little changed quarter-over-quarter from $309000.0 in Q4 2017.
Enlivex (ENLV) Preferred Shares (2017 - 2018) Analysis & Trends
Enlivex's Preferred Shares history runs 2 years deep, the most recent figure standing at $309000.0 for Q4 2018.
- In Q4 2018, Preferred Shares changed 0.0% year-over-year to $309000.0; the TTM figure through Dec 2018 stood at $309000.0 (changed 0.0% YoY), while the FY2018 annual figure was $309000.0, changed 0.0% from the prior year.
- Preferred Shares for Q4 2018 stood at $309000.0, roughly flat from $309000.0 in the prior quarter.
- The five-year high for Preferred Shares was $309000.0 in Q4 2017, with the low at $309000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Enlivex | 4.51 Mn | -1.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 309,000.00 |
| Dec 31, 2017 | 309,000.00 |